The trademark ENERDAFIL was filed by ADAMED PHARMA S.A., a corporation established under the laws of the Republic of Poland (the "Applicant"). The application was published for oppositions on December 17, 2019, and received one opposition filed on March 16, 2020 by Novartis AG on Likelihood of confusion. the opponent was represented by MILOJEVIC, SEKULIC & ASSOCIATES, S.L. and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued March 16, 2020
The application was filed in Polish, and Polish was also language of all opposition proceedings (English was selected as the second language).
Change of name and professional address of the trademark registration was recorded on August 11, 2021. Appointment and Replacement of representative of the trademark registration was recorded on December 18, 2023.